Ex Vivo Study of Altered Mitral Apparatus Geometry in Functional Mitral Regurgitation
DOI:
https://doi.org/10.1532/HSF98.20091148Abstract
Background: Functional mitral regurgitation (FMR) in patients with ischemic or nonischemic cardiomyopathy has been related to several overlapping factors. In vivo, these factors are very difficult to study independently of dynamic processes, such as ventricular wall motion or annular contraction. We developed an ex vivo left ventricular model that allows independent variations of annular size, papillary muscle (PM) position, and transvalvular pressure. We tested the hypothesis that FMR is a consequence of an altered balance of the tethering and coapting forces acting on leaflets.
Methods: Measurements were made on 4 excised porcine valves under physiological pressures and flows. Testing was done by systematically varying annular size and PM position. We evaluated 3 annulus sizes (normal, 15% dilation, and 25% symmetric dilation) by sequentially displacing PMs in lateral, posterolateral, and apicoposterolateral positions.
Results: Our results show that annular dilation is a major determinant of mitral regurgitation. Displacement of PMs also affects the regurgitant flow, but to a much lesser degree. Apical and posterolateral PM displacement increases regurgitant flow to a higher degree than isolated lateral or posterolateral displacement. Increased transvalvular pressure decreases regurgitant flow for any given geometric configuration of the mitral valve (MV).
Conclusion: Clinically observed pathologic configurations of the MV can be accurately reproduced ex vivo by altering the tethering and coapting forces acting on mitral leaflets. Our results support the mechanism of mitral regurgitation in which increased tethering forces and decreased coapting forces acting on the leaflets create the regurgitant orifice.
References
Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. 1991. Dilated cardiomyopathy with mitral regurgitation: decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 122(pt 1):763-71.nChandraratna PA, Aronow WS. 1981. Mitral valve ring in normal vs dilated left ventricle: cross-sectional echocardiographic study. Chest 79:151-4.nEspino DM, Shepherd DE, Buchan KG. 2007. Effect of mitral valve geometry on valve competence. Heart Vessels 22:109-15.nHe S, Fontaine AA, Schwammenthal E, Yoganathan AP, Levine RA. 1997. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation 96:1826-34.nHung J, Otsuji Y, Handschumacher MD, Schwammenthal F, Levine RA. 1999. Mechanism of dynamic regurgitant orifice area variation in functional mitral regurgitation. J Am Coll Cardiol 33:538-45.nKomeda M, Glasson JR, Bolger AF, et al. 1997. Geometric determinants of ischemic mitral regurgitation. Circulation 96(suppl):II-128-33.nKono T, Sabbah HN, Rosman H, Alam M, Jafri S, Goldstein S. 1992. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 20:1594-8.nKunzelman KS, Cochran RP, Verrier ED, Eberhart RC. 1994. Anatomic basis for mitral valve modelling. J Heart Valve Dis 3:491-6.nNielsen SL, Nygaard H, Fontaine AA, Hasenkam JM, He S, Yoganathan AP. 1999. Papillary muscle misalignment causes multiple mitral regurgitant jets: an ambiguous mechanism for functional mitral regurgitation. J Heart Valve Dis 8:551-64.nOtsuji Y, Handschumacher MD, Schwammenthal E, et al. 1997. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation 96:1999-2008.nOtsuji Y, Kumanohoso T, Yoshifuku S, et al. 2002. Isolated annular dilation does not usually cause important functional mitral regurgitation: comparison between patients with lone atrial fibrillation and those with idiopathic or ischemic cardiomyopathy. J Am Coll Cardiol 39:1651-6.nTahta SA, Oury JH, Maxwell JM, Hiro SP, Duran CM. 2002. Outcome after mitral valve repair for functional ischemic mitral regurgitation. J Heart Valve Dis 11:11-8.n